Hold and Kill: RIPTAC™ Therapeutics Present a Novel Mechanism to Conquer Cancer
Time: 11:30 am
day: Conference Day Two
Details:
- Describing a novel “hold & kill” approach to selectively treat cancers
- Elucidating the mechanism of action of RIPTACs
- Accelerating the proof-of-concept gain for further novel RIPTAC therapies
